Literature DB >> 8626624

CD39 is an ecto-(Ca2+,Mg2+)-apyrase.

T F Wang1, G Guidotti.   

Abstract

CD39, a 70- to 100-kDa molecule expressed primarily on activated lymphoid cells, was previously identified as a surface marker of Epstein Barr virus (EBV)-transformed B cells. In this report, we show that an ecto-(Ca2+,Mg2+)-apyrase activity is present on EBV-transformed B cells, but not on B or T lymphomas. The coincidence between CD39 expression and ecto-apyrase activity on immune cells suggests that CD39 may be an ecto-apyrase. This supposition is supported by the observation that the amino acid sequence of CD39 is significantly homologous to those of several newly identified nucleotide triphosphatases. Finally, we show that CD39 indeed has ecto-apyrase activity by expression in COS-7 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626624

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  A role for ectophosphatase in xenobiotic resistance.

Authors:  C Thomas; A Rajagopal; B Windsor; R Dudler; A Lloyd; S J Roux
Journal:  Plant Cell       Date:  2000-04       Impact factor: 11.277

2.  Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes.

Authors:  B P Chadwick; A M Frischauf
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

3.  Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.

Authors:  M Imai; K Takigami; O Guckelberger; K Enjyoji; R N Smith; Y Lin; E Csizmadia; J Sévigny; R D Rosenberg; F H Bach; S C Robson
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

4.  CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.

Authors:  Gregory M Hayes; Belinda Cairns; Zoia Levashova; Lawrence Chinn; Myra Perez; Jan-Willem Theunissen; Sindy Liao-Chan; Abel Bermudez; Mark R Flory; Karl J Schweighofer; Edward H van der Horst
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

5.  Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.

Authors:  B Berner; G Wolf; K M Hummel; G A Müller; M A Reuss-Borst
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

6.  Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.

Authors:  Eliezer Rapaport; Anna Salikhova; Edward H Abraham
Journal:  Purinergic Signal       Date:  2015-04-29       Impact factor: 3.765

Review 7.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

8.  Rat pancreas secretes particulate ecto-nucleotidase CD39.

Authors:  Christiane E Sørensen; Jan Amstrup; Hans N Rasmussen; Ieva Ankorina-Stark; Ivana Novak
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

9.  Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.

Authors:  Holger K Eltzschig; David Köhler; Tobias Eckle; Tianqing Kong; Simon C Robson; Sean P Colgan
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

10.  Expression, purification and crystallization of the ecto-enzymatic domain of rat E-NTPDase1 CD39.

Authors:  Xiaotian Zhong; Madhavan Buddha; Guido Guidotti; Ron Kriz; Will Somers; Lidia Mosyak
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.